Annual Net Income
-$17.57 M
-$6.13 M-53.57%
December 31, 2023
Summary
- As of March 6, 2025, OPRX annual net profit is -$17.57 million, with the most recent change of -$6.13 million (-53.57%) on December 31, 2023.
- During the last 3 years, OPRX annual net income has fallen by -$15.36 million (-695.88%).
- OPRX annual net income is now -4745.83% below its all-time high of $378.10 thousand, reached on December 31, 2021.
Performance
OPRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$9.12 M
-$5.12 M-127.64%
September 30, 2024
Summary
- As of March 6, 2025, OPRX quarterly net profit is -$9.12 million, with the most recent change of -$5.12 million (-127.64%) on September 30, 2024.
- Over the past year, OPRX quarterly net income has dropped by -$6.26 million (-218.46%).
- OPRX quarterly net income is now -772.27% below its all-time high of $1.36 million, reached on December 31, 2020.
Performance
OPRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$24.17 M
-$6.26 M-34.94%
September 30, 2024
Summary
- As of March 6, 2025, OPRX TTM net profit is -$24.17 million, with the most recent change of -$6.26 million (-34.94%) on September 30, 2024.
- Over the past year, OPRX TTM net income has dropped by -$10.42 million (-75.81%).
- OPRX TTM net income is now -2274.21% below its all-time high of $1.11 million, reached on September 30, 2021.
Performance
OPRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
OPRX Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -53.6% | -218.5% | -75.8% |
3 y3 years | -695.9% | -1563.3% | -6493.3% |
5 y5 years | -7862.2% | -359.7% | -669.2% |
OPRX Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -4745.8% | at low | -1563.3% | at low | -6493.3% | at low |
5 y | 5-year | -4745.8% | at low | -772.3% | at low | -2274.2% | at low |
alltime | all time | -4745.8% | at low | -772.3% | at low | -2274.2% | at low |
OptimizeRx Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$9.12 M(+127.6%) | -$24.17 M(+34.9%) |
Jun 2024 | - | -$4.01 M(-41.9%) | -$17.91 M(-0.8%) |
Mar 2024 | - | -$6.90 M(+66.6%) | -$18.07 M(+2.9%) |
Dec 2023 | -$17.57 M(+53.6%) | -$4.14 M(+44.6%) | -$17.57 M(+27.8%) |
Sep 2023 | - | -$2.87 M(-31.1%) | -$13.75 M(-4.2%) |
Jun 2023 | - | -$4.16 M(-35.0%) | -$14.35 M(+2.0%) |
Mar 2023 | - | -$6.40 M(+1863.8%) | -$14.08 M(+23.1%) |
Dec 2022 | -$11.44 M(-3125.2%) | -$325.80 K(-90.6%) | -$11.44 M(+9.1%) |
Sep 2022 | - | -$3.47 M(-10.8%) | -$10.49 M(+50.2%) |
Jun 2022 | - | -$3.88 M(+3.3%) | -$6.98 M(+154.3%) |
Mar 2022 | - | -$3.76 M(-703.2%) | -$2.75 M(-826.2%) |
Dec 2021 | $378.10 K(-117.1%) | $623.50 K(+1462.7%) | $378.10 K(-66.0%) |
Sep 2021 | - | $39.90 K(-88.7%) | $1.11 M(+40.9%) |
Jun 2021 | - | $352.10 K(-155.2%) | $789.00 K(-223.2%) |
Mar 2021 | - | -$637.40 K(-147.0%) | -$640.60 K(-71.0%) |
Dec 2020 | -$2.21 M(-29.8%) | $1.36 M(-579.7%) | -$2.21 M(-60.2%) |
Sep 2020 | - | -$282.90 K(-73.7%) | -$5.55 M(-18.8%) |
Jun 2020 | - | -$1.08 M(-51.1%) | -$6.84 M(+27.7%) |
Mar 2020 | - | -$2.20 M(+11.0%) | -$5.35 M(+70.3%) |
Dec 2019 | -$3.14 M(-1488.7%) | -$1.98 M(+26.3%) | -$3.14 M(+147.9%) |
Sep 2019 | - | -$1.57 M(-486.4%) | -$1.27 M(-331.3%) |
Jun 2019 | - | $406.60 K(+6155.4%) | $548.10 K(+29.9%) |
Mar 2019 | - | $6500.00(-105.9%) | $422.00 K(+86.5%) |
Dec 2018 | $226.30 K(-110.8%) | -$109.90 K(-144.9%) | $226.30 K(+128.4%) |
Sep 2018 | - | $244.90 K(-12.7%) | $99.10 K(-112.9%) |
Jun 2018 | - | $280.50 K(-248.3%) | -$768.60 K(-45.5%) |
Mar 2018 | - | -$189.20 K(-20.2%) | -$1.41 M(-33.0%) |
Dec 2017 | -$2.10 M(+36.7%) | -$237.10 K(-61.9%) | -$2.10 M(-5.2%) |
Sep 2017 | - | -$622.80 K(+72.3%) | -$2.22 M(+20.7%) |
Jun 2017 | - | -$361.50 K(-59.0%) | -$1.84 M(-11.1%) |
Mar 2017 | - | -$882.70 K(+150.2%) | -$2.07 M(+34.5%) |
Dec 2016 | -$1.54 M | -$352.80 K(+45.4%) | -$1.54 M(-3.9%) |
Sep 2016 | - | -$242.60 K(-59.0%) | -$1.60 M(+26.0%) |
Jun 2016 | - | -$591.90 K(+68.2%) | -$1.27 M(+52.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | -$351.90 K(-15.1%) | -$835.90 K(+40.4%) |
Dec 2015 | -$595.10 K(-42.0%) | -$414.70 K(-571.8%) | -$595.20 K(-1281.0%) |
Sep 2015 | - | $87.90 K(-155.9%) | $50.40 K(-115.2%) |
Jun 2015 | - | -$157.20 K(+41.4%) | -$332.00 K(-11.3%) |
Mar 2015 | - | -$111.20 K(-148.2%) | -$374.40 K(-63.5%) |
Dec 2014 | -$1.03 M(+283.6%) | $230.90 K(-178.4%) | -$1.03 M(-9.6%) |
Sep 2014 | - | -$294.50 K(+47.5%) | -$1.13 M(+15.6%) |
Jun 2014 | - | -$199.60 K(-73.8%) | -$980.80 K(+44.0%) |
Mar 2014 | - | -$762.10 K(-722.6%) | -$681.30 K(+374.4%) |
Dec 2013 | -$267.30 K(-41.2%) | $122.40 K(-186.5%) | -$143.60 K(-39.6%) |
Sep 2013 | - | -$141.50 K(-241.6%) | -$237.60 K(+17.4%) |
Jun 2013 | - | $99.90 K(-144.5%) | -$202.30 K(-46.5%) |
Mar 2013 | - | -$224.40 K(-890.1%) | -$378.30 K(-16.8%) |
Dec 2012 | -$454.60 K(-78.6%) | $28.40 K(-126.7%) | -$454.60 K(-21.1%) |
Sep 2012 | - | -$106.20 K(+39.6%) | -$576.10 K(-63.0%) |
Jun 2012 | - | -$76.10 K(-74.7%) | -$1.56 M(-23.7%) |
Mar 2012 | - | -$300.70 K(+223.0%) | -$2.04 M(-3.7%) |
Dec 2011 | -$2.12 M(+5.6%) | -$93.10 K(-91.4%) | -$2.12 M(-11.5%) |
Sep 2011 | - | -$1.09 M(+94.1%) | -$2.40 M(+32.1%) |
Jun 2011 | - | -$560.20 K(+47.5%) | -$1.81 M(-14.8%) |
Mar 2011 | - | -$379.90 K(+3.1%) | -$2.13 M(+5.9%) |
Dec 2010 | -$2.01 M(-55.9%) | -$368.60 K(-27.0%) | -$2.01 M(-49.4%) |
Sep 2010 | - | -$504.60 K(-42.3%) | -$3.97 M(-2.7%) |
Jun 2010 | - | -$874.90 K(+235.2%) | -$4.08 M(+15.0%) |
Mar 2010 | - | -$261.00 K(-88.8%) | -$3.55 M(-23.7%) |
Dec 2009 | -$4.56 M(+7.2%) | -$2.33 M(+279.5%) | -$4.65 M(-17.9%) |
Sep 2009 | - | -$614.10 K(+79.5%) | -$5.66 M(+8.7%) |
Jun 2009 | - | -$342.10 K(-74.9%) | -$5.21 M(-3.6%) |
Mar 2009 | - | -$1.36 M(-59.3%) | -$5.40 M(+17.7%) |
Dec 2008 | -$4.25 M(+1075.4%) | -$3.35 M(+1973.0%) | -$4.59 M(+268.7%) |
Sep 2008 | - | -$161.40 K(-69.8%) | -$1.25 M(+14.9%) |
Jun 2008 | - | -$535.20 K(-2.4%) | -$1.08 M(+97.6%) |
Mar 2008 | - | -$548.50 K | -$548.50 K |
Dec 2007 | -$361.50 K | - | - |
FAQ
- What is OptimizeRx annual net profit?
- What is the all time high annual net income for OptimizeRx?
- What is OptimizeRx annual net income year-on-year change?
- What is OptimizeRx quarterly net profit?
- What is the all time high quarterly net income for OptimizeRx?
- What is OptimizeRx quarterly net income year-on-year change?
- What is OptimizeRx TTM net profit?
- What is the all time high TTM net income for OptimizeRx?
- What is OptimizeRx TTM net income year-on-year change?
What is OptimizeRx annual net profit?
The current annual net income of OPRX is -$17.57 M
What is the all time high annual net income for OptimizeRx?
OptimizeRx all-time high annual net profit is $378.10 K
What is OptimizeRx annual net income year-on-year change?
Over the past year, OPRX annual net profit has changed by -$6.13 M (-53.57%)
What is OptimizeRx quarterly net profit?
The current quarterly net income of OPRX is -$9.12 M
What is the all time high quarterly net income for OptimizeRx?
OptimizeRx all-time high quarterly net profit is $1.36 M
What is OptimizeRx quarterly net income year-on-year change?
Over the past year, OPRX quarterly net profit has changed by -$6.26 M (-218.46%)
What is OptimizeRx TTM net profit?
The current TTM net income of OPRX is -$24.17 M
What is the all time high TTM net income for OptimizeRx?
OptimizeRx all-time high TTM net profit is $1.11 M
What is OptimizeRx TTM net income year-on-year change?
Over the past year, OPRX TTM net profit has changed by -$10.42 M (-75.81%)